Quest Diagnostics SVP Sells $2,686,708 in Stock (DGX)
Quest Diagnostics (NYSE:DGX) SVP Catherine Doherty unloaded 43,334 shares of the company’s stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $62.00, for a total transaction of $2,686,708.00. Following the completion of the sale, the senior vice president now directly owns 72,295 shares in the company. The transaction was disclosed in a document filed with the SEC, which is available at this link.
A number of research firms have recently commented on DGX. Analysts at Maxim Group reiterated a “buy” rating on shares of Quest Diagnostics (NYSE:DGX) in a research note to investors on Thursday, September 5th. They now have a $73.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Quest Diagnostics (NYSE:DGX) in a research note to investors on Friday, July 19th. They now have a $62.00 price target on the stock.
Two analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $60.93.
Shares of Quest Diagnostics (NYSE:DGX) traded up 0.03% on Wednesday, hitting $62.00. The stock had a trading volume of 1,352,187 shares. Quest Diagnostics has a 52 week low of $55.16 and a 52 week high of $64.87. The stock has a 50-day moving average of $59.49 and a 200-day moving average of $59.08. The company has a market cap of $9.417 billion and a price-to-earnings ratio of 18.91.
Quest Diagnostics (NYSE:DGX) last posted its quarterly earnings results on Thursday, July 18th. The company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.10 by $0.04. The company had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the company posted $1.17 earnings per share. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. Analysts expect that Quest Diagnostics will post $4.34 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 16th. Shareholders of record on Tuesday, October 1st will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.94%. The ex-dividend date of this dividend is Friday, September 27th.
Quest Diagnostics Incorporated (NYSE:DGX)is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.